Table 2.
Univariate and multivariate analysis for overall survival in patients with prostate cancer
| Characteristic | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | |
| Age | 0.895 (0.563–1.498) | 0.754 | – | – |
| Preoperative PSA (ng/ml) | 2.145 (1.284–3.315) | 0.415 | – | – |
| Gleason score | 1.432 (0.895–2.546) | 0.023* | 1.365 (0.968–2.584) | 0.056 |
| TNM stage | 2.312 (1.204–2.978) | 0.005* | 2.542 (1.432–3.142) | 0.024* |
| Metastasis | 3.142 (2.142–4.321) | 0.064 | – | – |
| MiR-5195-3p expression | 1.759 (1.006–2.153) | 0.014* | 2.132 (1.354–2.856) | 0.007* |
*p < 0.05